Microbiota and short chain fatty acid relationships underlie clinical heterogeneity and identify key microbial targets in irritable bowel syndrome (IBS)
Related Posts
Anukam DC, Nianogo RA, Arah OA, Rao J, Fowke JH, Hashibe M, Zhang ZF. Sleep duration and prostate cancer-specific mortality in the Southern Community Cohort[...]
Eibl G, Hines OJ, Rozengurt E. Prevention Before Therapy in Pancreatic Ductal Adenocarcinoma: The Clinical, Economic, and Human Case for Weighting Resources Upstream. Cancer Prev[...]
Wangrattanapranee P, Jensen DM, Jensen ME, Thibodeau G. Arterial blood flow detection and clinical outcomes of patients with flat spots and diverticular hemorrhage. IGIE. 2025[...]